TrialPloS one2018

Exploring the insulin secretory properties of the PGD2-GPR44/DP2 axis in vitro and in a randomized phase-1 trial of type 2 diabetes patients.

Stanko Skrtic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.